"This report presents the findings of the first phase of the [World Health Organization's] national Good Governance for Medicines programme in Lebanon. The assessment aims to obtain a picture of the level of transparency and potential vulnerability to corruption in the public pharmaceutical sector using WHO’s assessment instrument. In Lebanon, the assessment looked at six functions: medicines registration, inspection of pharmaceutical establishments, promotion, selection, procurement and distribution"
View webpage for full text
Type of material